From the AFR story today.
L1 Capital owns more than 9 per cent of St Barbara and chief investment officer Raphael Lamm and said it would be “highly disappointing” if a rival suitor to Genesis was not embraced by the St Barbara board.“I find this further revelation ... to be highly disappointing,” he said. “I call on the St Barbara board to finally enable all interested parties to be invited for discussions and if relevant, due diligence.”
also
But Baker Steel Capital Managers partner David Baker said he hoped St Barbara’s board could negotiate a delay to the shareholder meeting beyond June 30 to create the time and space for all bids to be considered.
So a couple of our largest shareholders are pressuring the board. I think there is more to play out here so imo it is a little premature to be firing off the voting form. Be informed as possible before committing.
- Forums
- ASX - By Stock
- SBM
- News: SBM St Barbara Determines Not To Engage With Silver Lake
SBM
st barbara limited
Add to My Watchlist
1.72%
!
28.5¢

News: SBM St Barbara Determines Not To Engage With Silver Lake, page-16
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
28.5¢ |
Change
-0.005(1.72%) |
Mkt cap ! $308.6M |
Open | High | Low | Value | Volume |
29.0¢ | 29.5¢ | 28.0¢ | $2.028M | 7.071M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 1069835 | 28.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 271064 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1049835 | 0.280 |
9 | 1058518 | 0.275 |
14 | 326002 | 0.270 |
2 | 120000 | 0.265 |
1 | 400000 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 271064 | 5 |
0.295 | 1114119 | 13 |
0.300 | 877812 | 19 |
0.305 | 423542 | 8 |
0.310 | 879403 | 10 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
SBM (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online